PCOS is a chronic condition with no known cure, but it is manageable. GLP-1 medications can help manage some of the symptoms, particularly weight gain and insulin resistance, which are central to the condition.

Yes, Semaglutide has been shown to support significant weight loss, which can be particularly beneficial for women with PCOS. Weight loss can help manage symptoms such as insulin resistance, irregular periods, and excess androgen levels. However, it’s important to note that while Semaglutide aids in weight loss, it does not cure PCOS. Always consult with your healthcare provider before starting any new medication.

Tirzepatide is a newer medication that targets both GLP-1 and GIP receptors, potentially offering greater weight loss compared to Semaglutide, which targets only GLP-1 receptors. For women with PCOS, Tirzepatide might provide more effective weight management, which is key in reducing PCOS symptoms. However, the choice between Tirzepatide and Semaglutide should be made in consultation with your healthcare provider based on your specific health needs.

Tirzepatide is generally considered safe for women with PCOS, particularly those struggling with weight management. It can help improve insulin sensitivity and reduce weight, which are critical factors in managing PCOS. As with any medication, it’s important to discuss potential risks and benefits with your healthcare provider.

The most common side effects of both Semaglutide and Tirzepatide include nausea, vomiting, and diarrhea, especially when first starting the medication. These symptoms usually decrease as your body adjusts. It’s important to monitor your symptoms and stay in close communication with your healthcare provider to ensure the medication is right for you.

Results can vary from person to person, but many women begin to see weight loss within a few weeks of starting Semaglutide or Tirzepatide. Significant weight loss typically occurs over a period of several months. Consistent use of the medication, along with a healthy diet and regular exercise, is key to achieving and maintaining results.

At this time GobyMeds does not accept medical insurance, and while GobyMeds does not communicate directly with your insurance company, our Patient Portal will provide you with an invoice that you can download and submit on your own in accordance with the policies of your insurance provider.

GobyMeds medical providers will conduct a thorough assessment of your medical history, including medication, allergies, past treatments, and other key points of information to determine which treatment option is best for you.

If approved, the medical provider may issue a prescription for one of our compounded GLP-1 medications, either Semaglutide or Tirzepatide.

Compounded GLP-1 medications are prescribed by our medical partners and contain the same active pharmaceutical ingredient as name brand FDA approved GLP-1 medications like Zepbound®, Mounjaro®, Ozempic® and Wegovy®.

Yes, compounded GLP-1 medications must be prescribed by a medical provider. At GobyMeds, the visit with our medical provider and prescription is included in our pricing, and if you are not medically approved you will be issued a full refund!

GobyMeds only works with best state-licensed compounding pharmacies to fulfill our prescriptions. We assess each of our pharmacy partners for quality and safety, and only use pharmacy partners that meet our very high standard. All pharmacy partners that we work with are sterile compounding 503A pharmacies.